Other OTC Pharmaceuticals - Ghana

  • Ghana
  • In the year 2024, the revenue generated in the Other OTC Pharmaceuticals market in Ghana amounts to US$17.63m.
  • It is projected that this market will experience an annual growth rate of 1.63% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue in this market, with a total of US$7,171.00m in 2024.
  • Considering the population figures, in 2024, the per person revenue in Ghana amounts to US$0.51.
  • Ghana's Other OTC Pharmaceuticals market is experiencing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Ghana is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory.Customer preferences in Ghana are driving the growth of the Other OTC Pharmaceuticals market. Ghanaians are increasingly seeking self-care options for minor health issues. They value convenience and affordability, and prefer to purchase over-the-counter medications without a prescription. This shift in consumer behavior is fueling the demand for Other OTC Pharmaceuticals in the country.Trends in the market further support the growth of the Other OTC Pharmaceuticals market in Ghana. The increasing availability and accessibility of these products in pharmacies and retail outlets have made them more widely accessible to consumers. Additionally, the growing awareness and education around self-care and the benefits of OTC medications have contributed to the rising demand. The market is also witnessing a surge in product innovation, with manufacturers introducing new and improved formulations to meet the specific needs of Ghanaian consumers.Local special circumstances in Ghana also play a role in the development of the Other OTC Pharmaceuticals market. The country has a relatively low doctor-to-patient ratio, which means that access to healthcare professionals may be limited for some individuals. As a result, Ghanaians are more inclined to rely on self-medication and over-the-counter remedies for common ailments. The cultural belief in traditional herbal medicine also influences consumer preferences, with many Ghanaians opting for natural remedies in addition to or instead of conventional OTC medications.Underlying macroeconomic factors further contribute to the growth of the Other OTC Pharmaceuticals market in Ghana. The country's economy has been steadily growing, leading to an increase in disposable income for many Ghanaians. This has resulted in higher purchasing power and greater affordability of OTC medications. Additionally, the government's efforts to improve healthcare infrastructure and promote self-care have created a favorable environment for the market to flourish.In conclusion, the Other OTC Pharmaceuticals market in Ghana is experiencing significant growth and development. Customer preferences for convenience and affordability, along with trends in the market such as increased accessibility and product innovation, are driving this growth. Local special circumstances, including limited access to healthcare professionals and the cultural preference for traditional medicine, also contribute to the market's expansion. Furthermore, underlying macroeconomic factors such as economic growth and government initiatives support the positive trajectory of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)